GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Osteopore Ltd (ASX:OSX) » Definitions » Change In Payables And Accrued Expense

Osteopore (ASX:OSX) Change In Payables And Accrued Expense : A$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Osteopore Change In Payables And Accrued Expense?

Osteopore's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was A$0.00 Mil. It means Osteopore's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Dec. 2023 .

Osteopore's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was A$0.00 Mil. It means Osteopore's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Osteopore Change In Payables And Accrued Expense Historical Data

The historical data trend for Osteopore's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Osteopore Change In Payables And Accrued Expense Chart

Osteopore Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial - - - - -

Osteopore Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only - - - - -

Osteopore Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Osteopore Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Osteopore's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Osteopore (ASX:OSX) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Osteopore Ltd (ASX:OSX) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
ISX:NICK ISX:HDIT ISX:TOYS ISX:IDEA ISX:KRYA ISX:LAJU ISX:MPOW ISX:KJEN ISX:EPAC ISX:IPAC ISRG XPAR:EL BDX XSWX:ALC TSE:7741 WST OCSE:COLO B RMD TSE:4543 XSWX:STMN
Traded in Other Exchanges
N/A
Address
Ground Floor, 16 Ord Street, West Perth, Perth, WA, AUS, 6005
Website
https://www.osteopore.com
Osteopore Ltd is engaged in the production of 3D printed bioresorbable implants that are used in conjunction with surgical procedures to assist bone healing. Its products include Osteoplug, which is a bioresorbable implant used for covering trephination burr holes in neurosurgery and Osteomesh which is a bioresorbable implant used in craniofacial surgery. Business operating segments are based on the firm's geographical presence in Singapore and Australia.

Osteopore (ASX:OSX) Headlines

No Headlines